Article citationsMore>>

Krog, G.R., Donneborg, M.L., Hansen, B.M., Lorenzen, H., Clausen, F.B., Jensen, K.V., et al. (2020) Prediction of ABO Hemolytic Disease of the Newborn Using Pre-and Perinatal Quantification of Maternal Anti-A/Anti-B IgG Titer. Pediatric Research, 90, 74-81.
https://doi.org/10.1038/s41390-020-01232-5

has been cited by the following article:

• TITLE: Advances in Biomarkers of Neonatal Hyperbilirubinemia

  AUTHORS: Qianshi Sun, Zixuan Ye, Tingting Wu, Qihong Fan

  KEYWORDS: Neonatal Hyperbilirubinemia, Bilirubin Encephalopathy, Biomarker

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.13 No.8, August 19, 2025

  ABSTRACT: Neonatal hyperbilirubinemia (NHB) is a common neonatal disease in clinical practice, and bilirubin encephalopathy caused by excessive free bilirubin across the blood-brain barrier causes irreversible neurological damage to the central nervous system, which is the most serious complication. Therefore, early prediction of NHB, early diagnosis, and intervention are significant to prevent the emergence of serious complications of NHB. In recent years, with the development of science and technology, molecular biology and genomics, a variety of novel biomarkers have been discovered and applied to the clinic. This article focuses on NHB-related biomarkers and also discusses the value of these biomarkers in disease prediction, diagnosis, prognosis assessment, and treatment monitoring, which will provide a reference for clinical practice and future research.